as of 10-30-2026 3:36pm EST
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.
| Founded: | 1984 | Country: | United States |
| Employees: | N/A | City: | ST LOUIS |
| Market Cap: | 34.0B | IPO Year: | 2001 |
| Target Price: | $74.50 | AVG Volume (30 days): | 3.9M |
| Analyst Decision: | Buy | Number of Analysts: | 21 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 5.15 | EPS Growth: | -314.42 |
| 52 Week Low/High: | $31.63 - $72.50 | Next Earning Date: | 10-27-2026 |
| Revenue: | $194,777,000,000 | Revenue Growth: | 19.44% |
| Revenue Growth (this year): | 12.83% | Revenue Growth (next year): | -2.31% |
| P/E Ratio: | 13.27 | Index: | |
| Free Cash Flow: | 4.3B | FCF Growth: | +17.49% |
Secretary & General Counsel
Avg Cost/Share
$65.36
Shares
47,603
Total Value
$3,111,332.08
Owned After
305,353.991
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| KOSTER CHRISTOPHER | CNC | Secretary & General Counsel | Aug 18, 2026 | Sell | $65.36 | 47,603 | $3,111,332.08 | 305,353.991 |
SEC 8-K filings with transcript text
Oct 27, 2026 · 100% conf.
1D
-6.99%
$63.02
Act: -2.54%
5D
-6.93%
$63.06
20D
-6.50%
$63.35
2 a20261027ex991pressrelease.htm
Document
Exhibit 99.1
Contact:Investor Relations InquiriesMedia Inquiries
Jennifer GilliganSara Garland
Senior Vice President, Finance & Investor RelationsChief Communications Officer
(212) 549-1306(314) 445-0790
-- Third Quarter GAAP Diluted Loss Per Share of $(0.14); Adjusted Diluted Earnings Per Share of $0.58 --
-- Increases 2026 GAAP Diluted EPS Guidance: Greater than $3.46 & Adjusted Diluted EPS Greater than $5.20 --
•Increases 2026 full year adjusted diluted EPS guidance by $0.40.
•Consolidated HBR of 92.7% in the third quarter, better than expectations, driven by the Medicare segment, with Medicaid and Marketplace on track.
•Full year 2026 HBR mid-point expectation improved by 15 basis points to 90.75%.
•Debt reduced by $1.1 billion since June 30, 2026, including full redemption of 2027 Senior Notes in October.
ST. LOUIS, October 27, 2026 -- Centene Corporation (NYSE: CNC) (the Company) announced today its financial results for the third quarter ended September 30, 2026. In summary, the 2026 third quarter results were as follows:
Total revenues (in millions)$50,647
Premium and service revenues (in millions)$45,105
Health benefits ratio92.7 %
SG&A expense ratio7.2 %
Adjusted SG&A expense ratio (1) 6.5 %
GAAP diluted loss per share$(0.14)
Adjusted diluted earnings per share (1) $0.58
Total cash flow (used in) operations (in millions)$(3,669)
(1)
Represents a non-GAAP financial measure. A full reconciliation of the adjusted diluted earnings (loss) per share and adjusted selling, general and administrative (SG&A) expenses is shown in the Non-GAAP Financial Presentation section of this release.
"Solid underlying fundamentals within our core businesses have powered a faster recovery to our earnings trajectory than previously anticipated," said Chief Executive Officer of Centene, Sarah M. London. "We are pleased with the progress our teams have made in delivering increased margin to power our mission of transforming the health of the communities we serve, one person at a time. We remain focused on a strong finish to 2026 and building on this progress in 2027."
1
Membership
The following table sets forth membership by line of business:
September 30,
20262025
Traditional Medicaid (1) 10,544,300 11,115,400
High Acuity Medicaid (2) 1,351,600 1,591,000
Total Medicaid11,895,900 12,706,400
Marketplace3,403,300 5,828,100
Individual and Commercial Group (3) 497,400 447,900
Total Commercial3,900,700 6,276,000
Medicare (4) 954,400 1,013,200
Medicare Prescription Drug Plan (PDP) 8,947,200 7,972,500
Total at-risk membership25,698,200 27,968,100
(1)
Membership includes Temporary Assistance for Needy Families (TANF), Medicaid Expansion, Children's Health Insurance Program (CHIP), Foster Care, and Behavioral Health.
(2)
Membership includes Aged, Blind, or Disabled (ABD), Intellectual and Developmental Disabilities (IDD), Long-Term Services and Supports (LTSS), and Medicare-Medicaid Plans (MMP) Duals. The Company operated MMPs through December 31, 2025. In 2026 these members are included in Medicare as a result of the Centers for Medicare and Medicaid Services (CMS) transition to Dual Eligible Special Needs Plans (D-SNP) based integration.
(3)
Membership includes Commercial Group, CHOICE Arrangements (formerly Individual Coverage Health Reimbursement Arrangement, or ICHRA) and Other Off-Exchange Individual.
(4)
Membership includes Medicare Advantage, Medicare Supplement, and Applicable Integrated Plans (AIPs) as a result of the CMS transition to D-SNP based integration in 2026.
Premium and Service Revenues
The following table sets forth supplemental revenue information ($ in millions):
Three Months Ended September 30,
20262025% Change
Medicaid$24,039 $23,171 4 %
Commercial8,700 10,992 (21)%
Medicare (1) 11,263 9,391 20 %
Other1,103 1,344 (18)%
Total premium and service revenues$45,105 $44,898 0.5 %
(1)
Medicare includes Medicare Advantage, Medicare PDP and Medicare Supplement.
Statement of Operations: Three Months Ended September 30, 2026
•For the third quarter of 2026, premium and service revenues increased 0.5% to $45.1 billion from $44.9 billion in the comparable period of 2025. The increase was primarily driven by premium yield and membership growth in the PDP business, rate increases in Marketplace and in the Medicaid business to address medical trend, Marketplace risk adjustment revenue transfer for the 2026 benefit year, and state directed payments. The increases were partially offset by lower Marketplace and Medicaid membership.
•Health benefits ratio (HBR) of 92.7% for the third quarter of 2026, unchanged from 92.7% in the comparable period in 2025. The consolidated HBR benefited from a lower Marketplace HBR resulting from improved pricing and risk transfer reflecting the acuity of the Marketplace members
Jul 28, 2026 · 100% conf.
1D
-7.41%
$59.38
Act: -3.65%
5D
-7.79%
$59.13
20D
-7.49%
$59.33
2 a20260728ex991pressrelease.htm
Document
Exhibit 99.1
Contact:Investor Relations InquiriesMedia Inquiries
Jennifer GilliganSara Garland
Senior Vice President, Finance & Investor RelationsChief Communications Officer
(212) 549-1306(314) 445-0790
-- Second Quarter GAAP Diluted Earnings Per Share of $2.19; Adjusted Diluted Earnings Per Share of $2.51 --
-- Increases 2026 GAAP Diluted EPS Guidance: Greater than $3.11 & Adjusted Diluted EPS Greater than $4.80 --
•Commercial HBR of 79.2%, demonstrating significant year-over-year improvement in profitability.
•Medicare segment HBR of 89.5%, including fundamental outperformance in both Medicare Advantage and PDP.
•Medicaid HBR of 93.9%, in-line with expectations and reflecting continued execution in management of medical cost trend.
•Guidance increase resulting from underlying strength of the business, including approximately $0.50 of non-recurring items in Medicare and Commercial segments.
ST. LOUIS, July 28, 2026 -- Centene Corporation (NYSE: CNC) (the Company) announced today its financial results for the second quarter ended June 30, 2026. In summary, the 2026 second quarter results were as follows:
Total revenues (in millions)$53,579
Premium and service revenues (in millions)$44,375
Health benefits ratio89.6 %
SG&A expense ratio7.0 %
Adjusted SG&A expense ratio (1) 6.9 %
GAAP diluted earnings per share$2.19
Adjusted diluted earnings per share (1) $2.51
Total cash flow provided by operations (in millions)$3,590
(1)
Represents a non-GAAP financial measure. A full reconciliation of the adjusted diluted earnings per share (EPS) and adjusted selling, general and administrative (SG&A) expenses is shown in the Non-GAAP Financial Presentation section of this release.
"Our second quarter results and improved full-year outlook represent meaningful milestones on our path to restoring profitability and increasing shareholder value," said Chief Executive Officer of Centene, Sarah M. London. "We are excited by the positive momentum we have built and remain focused on our goal of delivering industry-leading health outcomes with an industry-leading cost structure."
1
Membership
The following table sets forth membership by line of business:
June 30,
20262025
Traditional Medicaid (1) 10,745,800 11,227,400
High Acuity Medicaid (2) 1,364,900 1,592,300
Total Medicaid12,110,700 12,819,700
Marketplace3,494,700 5,862,800
Individual and Commercial Group (3) 497,000 449,700
Total Commercial3,991,700 6,312,500
Medicare (4) 980,000 1,026,900
Medicare Prescription Drug Plan (PDP) 8,803,000 7,845,800
Total at-risk membership25,885,400 28,004,900
(1)
Membership includes Temporary Assistance for Needy Families (TANF), Medicaid Expansion, Children's Health Insurance Program (CHIP), Foster Care, and Behavioral Health.
(2)
Membership includes Aged, Blind, or Disabled (ABD), Intellectual and Developmental Disabilities (IDD), Long-Term Services and Supports (LTSS), and Medicare-Medicaid Plans (MMP) Duals. The Company operated MMPs through December 31, 2025. In 2026 these members are included in Medicare as a result of the Centers for Medicare and Medicaid Services (CMS) transition to Dual Eligible Special Needs Plans (D-SNP) based integration.
(3)
Membership includes Commercial Group, Individual Coverage Health Reimbursement Arrangement (ICHRA) and Other Off-Exchange Individual.
(4)
Membership includes Medicare Advantage, Medicare Supplement, and Applicable Integrated Plans (AIPs) as a result of the CMS transition to D-SNP based integration in 2026.
Premium and Service Revenues
The following table sets forth supplemental revenue information ($ in millions):
Three Months Ended June 30,
20262025% Change
Medicaid$22,766 $21,723 5 %
Commercial9,356 10,070 (7)%
Medicare (1) 11,057 9,450 17 %
Other1,196 1,224 (2)%
Total premium and service revenues$44,375 $42,467 4 %
(1)
Medicare includes Medicare Advantage, Medicare PDP and Medicare Supplement.
Statement of Operations: Three Months Ended June 30, 2026
•For the second quarter of 2026, premium and service revenues increased 4% to $44.4 billion from $42.5 billion in the comparable period of 2025. The increase was primarily driven by premium yield and membership growth in the PDP business, rate increases in Marketplace and in the Medicaid business to address medical trend, Marketplace risk adjustment revenue transfer for the 2025 and 2026 benefit years, and state directed payments. The increases were partially offset by lower Marketplace and Medicaid membership.
•Health benefits ratio (HBR) of 89.6% for the second quarter of 2026 represents a decrease from 93.0% in the comparable period in 2025. The consolidated HBR benefited from a lower Marketplace HBR resulting from improved pricing and risk transfer reflecting the acuity of the Marketplace membership. The HBR also decrease
Apr 28, 2026 · 100% conf.
1D
+1.16%
$50.50
Act: +8.11%
5D
+5.26%
$52.54
Act: +6.09%
20D
+4.34%
$52.09
Act: +17.81%
2 a20260428ex991pressrelease.htm
Document
Exhibit 99.1
Contact:Investor Relations InquiriesMedia Inquiries
Jennifer GilliganSara Garland
Senior Vice President, Finance & Investor RelationsChief Communications Officer
(212) 549-1306(314) 445-0790
-- First Quarter GAAP Diluted Earnings Per Share of $3.11; Adjusted Diluted Earnings Per Share of $3.37 --
-- Increases 2026 GAAP Diluted EPS Guidance to Greater than $2.37 & Adjusted Diluted EPS to Greater than $3.40 --
•Strong first quarter 2026 adjusted diluted EPS of $3.37, approximately $0.50 better than our expectations.
•Medicaid HBR of 93.1%, reflecting continued tangible progress managing medical costs coupled with moderate flu.
•Medicare segment HBR of 84.9%, from outperformance in both Medicare Advantage and PDP.
•Commercial HBR of 75.3%, slightly above expectations, primarily reflecting higher acuity among Marketplace Silver Tier members prior to anticipated future 2026 net risk adjustment benefit. Marketplace pre-tax earnings for Q1 were in-line with expectations inclusive of favorable SG&A.
•$1.0 billion of debt reduction during the first quarter 2026.
ST. LOUIS, April 28, 2026 -- Centene Corporation (NYSE: CNC) (the Company) announced today its financial results for the first quarter ended March 31, 2026. In summary, the 2026 first quarter results were as follows:
Total revenues (in millions)$49,944
Premium and service revenues (in millions)$44,655
Health benefits ratio87.3 %
SG&A expense ratio7.6 %
Adjusted SG&A expense ratio (1) 7.6 %
GAAP diluted earnings per share$3.11
Adjusted diluted earnings per share (1) $3.37
Total cash flow provided by operations (in millions)$4,366
(1)
Represents a non-GAAP financial measure. A full reconciliation of the adjusted diluted earnings per share (EPS) and adjusted selling, general and administrative (SG&A) expenses is shown in the Non-GAAP Financial Presentation section of this release.
"We continue to make tangible progress in our margin recovery efforts while strengthening the fundamental operations of each of our businesses," said Chief Executive Officer of Centene, Sarah M. London. "Our strong first quarter results position us to increase our full year 2026 adjusted diluted EPS guidance to greater than $3.40. We remain confident in the long-term earnings power of the enterprise and motivated by the positive and lasting impact we can deliver for the families and communities we serve."
1
Awards & Community Engagement
•In March, the Centene Foundation and Carolina Complete Health, a Centene subsidiary, announced their investment in and groundbreaking of the Northeast Winston-Salem Choice Neighborhood Initiative. In partnership with McCormack Baron Salazar, the investment will help rebuild 244 affordable housing units and connect residents to essential healthcare and address community needs.
•In March, the Centene Foundation and WellCare of Kentucky, a Centene subsidiary, launched the WellCare Food is Medicine Program to address diabetes-related needs in rural Kentucky. The program will provide eligible Medicaid enrollees with diabetes access to weekly home-delivered, medically tailored meals, recipes, and educational materials for up to three years.
•In February, Buckeye Health Plan, a Centene subsidiary, announced awards to six Ohio healthcare providers under the Provider Accessibility Initiative, a program supported by the National Council on Independent Living's Barrier Removal Fund. The funding will be used to purchase equipment to support patients with disabilities and make ADA-compliant improvements to provider facilities, such as handrails, wheelchair ramps, and sliding doors.
•In January, Centene was named one of the World's Most Admired Companies™ by Fortune® for the eighth consecutive year. The distinction was determined based on Centene's quality of management and products, social responsibility, ability to attract talent, and more.
Membership
The following table sets forth membership by line of business:
March 31,
20262025
Traditional Medicaid (1) 10,923,100 11,369,400
High Acuity Medicaid (2) 1,503,800 1,589,400
Total Medicaid12,426,900 12,958,800
Marketplace3,582,200 5,626,000
Individual and Commercial Group (3) 481,000 448,200
Total Commercial4,063,200 6,074,200
Medicare (4) 1,002,200 1,043,200
Medicare Prescription Drug Plan (PDP) 8,780,600 7,867,800
Total at-risk membership26,272,900 27,944,000
(1)
Membership includes Temporary Assistance for Needy Families (TANF), Medicaid Expansion, Children's Health Insurance Program (CHIP), Foster Care, and Behavioral Health.
(2)
Membership includes Aged, Blind, or Disabled (ABD), Intellectual and Developmental Disabilities (IDD), Long-Term Services and Supports (LTSS), and Medicare-Medicaid Plans (MMP) Duals. The Company operated MMPs through December 31, 2025. In 2026 these members are inclu
See how CNC stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "CNC Centene Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.